fda compounding semaglutide news november 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs FDA Warns on Certain Forms

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

This direct delivery bypasses the skin barrier, which can limit the absorption of topically applied ingredients, ensuring more consistent and potent therapeutic levels

Safety and Monitoring - Always start with a low dose to assess tolerance

Utomo A, Jiang X, Furuta S, Yun J, Levin DS, Wang YC, Desai KV, Green JE, Chen PL, Lee WH

Another study 27 is currently investigating whether weight regain after total discontinuation can be mitigated by interventions including tailored meals and a mobile application that tracks food intake and exercise